Vitamin B7
Sickle Cell Anemia
National Heart, Lung, and Blood Institute (NHLBI)Small moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Sickle Cell Anemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Glutamine Ain Shams University | Phase 4 | BBB |
Sildenafil The Baruch Padeh Medical Center, Poriya | Phase 4 | BB |
L-Nmma National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | BB |
AMLODIPINE National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | BB |
Alpelisib National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | BB |
View all 40 →
Same molecule, other indications
Vitamin B7 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →